Fetal Parenchymatic Evaluation (Liver, Spleen) Using T2* Sequences
Recruitment status was Not yet recruiting
The purpose of this study is to prospectively evaluated the T2* values of normal feti.A standardized scale of T2* values for fetal and neonatal iron organ overload have yet to be reported or devised.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Fetal Parenchymatic Evaluation (Liver, Spleen) Using T2* Sequences.|
|Study Start Date:||June 2010|
|Estimated Study Completion Date:||June 2012|
|Estimated Primary Completion Date:||June 2012 (Final data collection date for primary outcome measure)|
The purpose of this study is to prospectively evaluate the T2* values of normal feti. This study will be offered to mothers undergoing fetal MRI for any indication. Subjects will be required to sign an informed consent from. The addition of T2* sequences will add 2-4 minutes to the whole scan, not exposing the mother or the fetus to ionizing radiation or the administration of contrast material. A standardized scale has been created and multi-center studies have been conducted using different vendor scanners in order to verify the consistency of these scale. T2 and T2* sequences have been addressed anecdotally in the literature as non invasive options for the evaluation fetal iron deposition . However, a standardized scale of T2* values for fetal and neonatal iron organ overload have yet to be reported or devised.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01121094
|Contact: Orly Goitein, MD||+972 3 firstname.lastname@example.org|
|Sheba medical center||Not yet recruiting|
|Tel Hashomer, Israel, 52621|
|Contact: Orly Goitein, MD +972 3 5302530|
|Principal Investigator: Orly Goitein, MD|